Skip to content

Clinical trials

Phase 2/3 Hemorrhage trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 2/3 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20101
20122
20131
20141
20171
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Rush University Medical Center2
Corewell Health East1
Jaeb Center for Health Research1
NICHD Neonatal Research Network1
University of Maryland, Baltimore1
University of Texas Southwestern Medical Center1
University of Washington1
Virginia Commonwealth University1
Yale University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage10
Blood Loss, Surgical3
Osteoarthritis2
Wounds and Injuries2
Anemia, Neonatal1
Arthritis1
Critical Illness1
Cross Infection1
Hemoptysis1
Infections1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.